Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Nozomu Fuse"'
Autor:
Chikako Funasaka, Akiko Hanai, Sadamoto Zenda, Keita Mori, Makoto Fukui, Nami Hirano, Rie Shinohara, Nozomu Fuse, Masashi Wakabayashi, Mai Itagaki, Yutaka Tomioka, Michihiko Nishina, Yasuaki Arai, Takahiro Kogawa, Yukinori Ozaki, Meiko Nishimura, Takayuki Kobayashi, Fumikata Hara, Toshimi Takano, Toru Mukohara
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundChemotherapy-induced peripheral neuropathy (CIPN) is one of the most common adverse events that can significantly impair the quality of life of patients. Although limb cooling may be beneficial for preventing CIPN, logistical challenges exi
Externí odkaz:
https://doaj.org/article/e1de7bd468ee4989bc20236eaa2dcef1
Autor:
Hideaki Bando, Daisuke Kotani, Takahiro Tsushima, Hiroki Hara, Shigenori Kadowaki, Ken Kato, Keisho Chin, Kensei Yamaguchi, Shun-ichiro Kageyama, Hidehiro Hojo, Masaki Nakamura, Hidenobu Tachibana, Masashi Wakabayashi, Miki Fukutani, Yosuke Togashi, Nozomu Fuse, Hiroyoshi Nishikawa, Takashi Kojima
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background The standard treatment for patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC) is definitive chemoradiotherapy (CRT) using 5-FU plus cisplatin. However, complete response (CR) rates are low at 11
Externí odkaz:
https://doaj.org/article/177fd65d37574541bcfba385232aad76
Autor:
Hideaki Bando, Atsushi Ohtsu, Takayuki Yoshino, Toshiki Masuishi, Hiroya Taniguchi, Daisuke Kotani, Yoshito Komatsu, Eiji Shinozaki, Takako Eguchi Nakajima, Taroh Satoh, Tomohiro Nishina, Taito Esaki, Masashi Wakabayashi, Shogo Nomura, Koji Takahashi, Hiromi Ono, Nami Hirano, Noriko Fujishiro, Nozomu Fuse, Akihiro Sato
Publikováno v:
ESMO Open, Vol 4, Iss 6 (2019)
Background BRAF V600E mutations are associated with aggressive biology and limited response to standard chemotherapy, especially during second-line and beyond therapies. BRAF V600E mutant and wild-type colorectal cancers (CRCs) differ in their expres
Externí odkaz:
https://doaj.org/article/d4dc360f8caa4a12beca9ac3e971093a
Autor:
Yasutoshi Sakamoto, Hideaki Bando, Yoshiaki Nakamura, Hiromi Hasegawa, Takako Kuwaki, Wataru Okamoto, Hiroya Taniguchi, Yoshihiro Aoyagi, Izumi Miki, Hiroshi Uchigata, Naomi Kuramoto, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu
Publikováno v:
Clinical colorectal cancer.
Utilizing real-world data (RWD) for effective clinical implementation is becoming more and more appealing as the cost of drug development rises, especially for patients with rare diseases and rare molecular subtypes for whom conducting randomized con
Autor:
Toshio Shimizu, Atsushi Ohtsu, Yukiko Komori, Kazuto Nishio, Hideaki Takahashi, Yutaka Kawakami, Yasutoshi Kuboki, Yuichi Ando, Noboru Yamamoto, Takahiro Nonaka, Koshin Kiyohara, Kazuhiro Sase, Naomi Kiyota, Nozomu Fuse, Shiro Kimbara, Hironobu Minami, Tomoya Shimokata, Shin-Ichi Nihira
Publikováno v:
Cancer Science
Clinical studies intended for regulatory approval must demonstrate the clinical benefits of the drug in a target population. Clinical development of a drug proceeds by stepwise clinical studies; after safety and pharmacokinetics are evaluated and the
Autor:
Hideaki Bando, Shogo Kumagai, Daisuke Kotani, Saori Mishima, Takumi Habu, Takahiro Tsushima, Hiroki Hara, Shigenori Kadowaki, Ken Kato, Keisho Chin, Kensei Yamaguchi, Shun-ichiro Kageyama, Hidehiro Hojo, Masaki Nakamura, Tachibana Hidenobu, Masashi Wakabayashi, Makoto Fukui, Nozomu Fuse, Hiroyoshi Nishikawa, Takashi Kojima
Publikováno v:
Journal of Clinical Oncology. 41:416-416
416 Background: Platinum-based definitive chemoradiotherapy (dCRT) is the standard treatment for patients (pts) with unresectable locally advanced esophageal squamous cell carcinoma (ESCC), invading the aorta, vertebral body, or trachea. However, com
Autor:
Yasutoshi Sakamoto, Hideaki Bando, Yoshiaki Nakamura, Hiromi Hasegawa, Takako Kuwaki, Wataru Okamoto, Hiroya Taniguchi, Yoshihiro Aoyagi, Izumi Miki, Hiroshi Uchigata, Naomi Kuramoto, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu, Sakamoto, Yasutoshi, Bando, Hideaki, Nakamura, Yoshiaki, Hasegawa, Hiromi, Kuwaki, Takako, Okamoto, Wataru
Publikováno v:
Clinical Colorectal Cancer; Mar2023, Vol. 22 Issue 1, p45-52, 8p
Autor:
Yuki Harada, Akihiro Sato, Waki Toya, Nozomu Fuse, Masahiro Tsuboi, Noriko Yamashita, Masahiko Ozaki
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 51:255-265
Autor:
Miki Fukutani, Kensei Yamaguchi, Nozomu Fuse, Hidenobu Tachibana, Masashi Wakabayashi, Hiroyoshi Nishikawa, Keisho Chin, Daisuke Kotani, Takashi Kojima, Ken Kato, Hidehiro Hojo, Hiroki Hara, Shigenori Kadowaki, Yosuke Togashi, Masaki Nakamura, Takahiro Tsushima, Shun Ichiro Kageyama, Hideaki Bando
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)
BMC Cancer
BMC Cancer
Background The standard treatment for patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC) is definitive chemoradiotherapy (CRT) using 5-FU plus cisplatin. However, complete response (CR) rates are low at 11–25%, re
Autor:
Tomomi Hata, Nozomu Fuse, Haruko Yamamoto, Shimon Tashiro, Jun Sakurai, Michihiko Wada, Yoichi Yamamoto, Hitoshi Ozawa, Nobuko Ushirozawa, Hideki Hanaoka, Tatsuya Maruyama, Shinobu Shimizu, Koji Todaka, Taro Shibata, Norihiro Sato, Natsuko Okita, Koji Ikeda, Kenichi Nakamura, Hiroi Kasai
Publikováno v:
Therapeutic Innovation & Regulatory Science
Background The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is undertaking a major revision of ICH E6 Good Clinical Practice (GCP) decided to involve external stakeholders in ICH-GCP renova